v3 Template
M

MediciNova, Inc.

Biopharmaceutical ~105 employees
Founded
--
Employees (Est.)
~105
7 leaders known
Total Funding
$30.0M
Funding Rounds
1
Last Funding
2025-07-31

About MediciNova, Inc.

MediciNova, Inc. is a biopharmaceutical company focused on developing novel therapeutics for neurology, respiratory, and liver diseases with unmet medical needs.

Products & Services

MN-166:A therapeutic for neurology diseases, targeting Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis (ALS), and Drug Dependence.
MN-221:A therapeutic for respiratory diseases, targeting Acute Exacerbations of Asthma and COPD Exacerbations.
MN-001:A therapeutic for fibrotic diseases, targeting Liver Fibrosis (NASH or others) and Pulmonary Fibrosis (IPF); also for non-core programs like Bronchial Asthma and Interstitial Cystitis.
MN-029:A therapeutic for cancer under non-core programs.

Specialties

Neurology Diseases Respiratory Diseases Liver Diseases Fibrotic Diseases

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Standby Equity Purchase Agreement
T: -
FT: Standby Equity Purchase Agreement 		A: 30000000
MR: -
FA: up to $30 million
FAN: 30000000 		D: 2025-07-31
FD: 2025-07-31 		2 investors
Standby Equity Purchase Agreement Latest
2025-07-31
$30.0M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

Y

Yuichi Iwaki

President and Chief Executive Officer, and Founder

H

Hideki Nagao

Member of the Board of Directors

K

Kazuko Matsuda

Chief Medical Officer

C

Carolyn Beaver

Member of the Board of Directors

N

Nicole Lemerond

Member of the Board of Directors

D

David H. Crean

Chief Business Officer

View 4 more team members with Pro

Unlock Full Team Directory

Recent News

MediciNova, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~105 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro